MD Anderson Cancer Center
1515 Holcombe Boulevard, Houston, Texas 77030
MD Anderson Cancer Center, the affiliate medical institution of the University of Texas, is a mesothelioma cancer center of excellence featuring some of the top specialists and researchers for mesothelioma. Patients often travel across the country to visit MD Anderson due to the center's sterling reputation for care of cancer patients.
Pleural Mesothelioma and Peritoneal Mesothelioma
MD Anderson Cancer Center
1515 Holcombe Boulevard
Houston, Texas
Dr. Anne Tsao
JUMP TO A TOPIC
More About Mesothelioma Treatment at MD Anderson Cancer Center
Mesothelioma is a rare and aggressive disease. Not many doctors have the training or experience to treat it effectively, which provides a challenge for patients and their families.
MD Anderson Cancer Center, located in Houston, Texas, is one of the world’s top mesothelioma cancer centers and patients often travel across the country for care. MD Anderson has the honor of being a National Cancer Institute-designated center. It is one of just a few in the state of Texas with this recognition.
Mesothelioma treatment provided at MD Anderson includes surgery and therapies on a case-by-case basis. This allows medical staff to provide a treatment plan for the unique needs of the individual patient.
Dr. Anne Tsao is the Director of the hospital’s Mesothelioma Program. Dr. Kanwal Raghay is the medical oncologist for peritoneal mesothelioma cases.
MD Anderson Cancer Center features a Thoracic Center, which houses treatment for pleural mesothelioma. MD Anderson also sees peritoneal mesothelioma cases.
There are four locations seeing people with mesothelioma:
- MD Anderson League City
- MD Anderson Sugar Land
- MD Anderson Woodlands
- MD Anderson West Houston
- Dr. Anne Tsao, Director of Mesothelioma Program
- Dr. Kanwal Raghay, gastrointestinal medical oncologist
- University of Texas
- Extrapleural pneumonectomy surgery (pleural mesothelioma)
- Pleurectomy/decortication surgery (pleural mesothelioma)
- Chemotherapy
- Immunotherapy
- Radiation therapy
- Targeted therapy, such as oncolytic virus therapy
Get Connected to MD Anderson Cancer Center
MD Anderson Cancer Center is a home to more than a dozen clinical studies involving mesothelioma. Dr. Anne Tsao is the Director of Mesothelioma at the hospital and leads a team of specialists offering surgery, chemotherapy, immunotherapy and more.
Why Choose MD Anderson?
- Ranked first in cancer treatment among all hospitals
- Offering a variety of therapy options for patients
- Highly skilled staff includes surgeons and oncologists
What Mesothelioma Care Is Like at MD Anderson
MD Anderson Cancer Center is ranked as the top hospital in America in 2024-2025 for cancer treatment. This is a testament to the quality of care patients experience and comfort they feel throughout the process.
Cancer care is not limited just to the medicines provided or surgeries performed. MD Anderson excels at easing the anxieties of cancer patients and their families. There are various housing programs used by the cancer center to help out-of-town traveling families regain a sense of normalcy through the challenging period.
MD Anderson also offers mental health services to improve patient quality of life before, during and after mesothelioma treatment.
For the fourth straight year, in 2024-2025, the U.S. News & World Report Best Hospitals Honor Roll ranked MD Anderson Cancer Center first among all hospitals and medical facilities in America for cancer treatment. This is a prestigious honor and evidence of the mesothelioma cancer center’s high-quality care for patients.
- Not ranked in the U.S. News & World Report 2024-2025 Hospitals Honor Roll
- Ranked 1st in cancer treatment
- Ranked 14th in gastrointestinal cancer surgery (peritoneal mesothelioma)
- High performing for lung cancer surgery (pleural mesothelioma)
Host Site for Mesothelioma Clinical Trials
MD Anderson Cancer Center is a regular Uhost site for mesothelioma clinical trials. One of the most prominent trials was the DREAM3R study featuring the immunotherapy drug durvalumab. The trial uses the immune checkpoint inhibitor with chemotherapy.
The trial is one of the recruiting studies at MD Anderson. There are a total of 16 clinical trials featuring malignant mesothelioma. One of them uses pleurectomy/decortication surgery after neoadjuvant chemotherapy and intensity-modulated radiation therapy.
MD Anderson hosted a phase 2 immunotherapy clinical trial for peritoneal mesothelioma. Doctors gave patients atezolizumab and bevacizumab, which achieved a 40% response rate. Patient survival before disease progression was also nearly 18 months, much better than systemic chemotherapy.
How to Begin Treatment at MD Anderson
MD Anderson Cancer Center is located in a major metropolitan city, which grants access to patients traveling by plane from hours away. The hospital welcomes patients from other states – or patients in far-away parts of Texas.
Connecting with MD Anderson is much easier with the help of a patient advocate. Nurse Karen Ritter is the best and most compassionate patient guide for mesothelioma patients. Her number one goal is to help connect people with the medical resources they need to improve their prognosis.
Email Nurse Karen at karen@mesotheliomaguide.com or request a list of cancer center recommendations based on your location, disease and other specific criteria.
Sources & Author
- Mesothelioma. MD Anderson Cancer Center. Retrieved from: https://www.mdanderson.org/cancer-types/mesothelioma.html. Accessed: 02/22/2022.
- University of Texas MD Anderson Cancer Center. U.S. News & World Report. Retrieved from: https://health.usnews.com/best-hospitals/area/tx/university-of-texas-md-anderson-cancer-center-6741945. Accessed: 07/25/2024.
- Mesothelioma Treatment. MD Anderson Cancer Center. Retrieved from: https://www.mdanderson.org/cancer-types/mesothelioma/mesothelioma-treatment.html. Accessed: 02/22/2022.
- Find a Cancer Center. National Cancer Institute. Retrieved from: https://www.cancer.gov/research/infrastructure/cancer-centers/find. Accessed: 03/03/2022.
- Atezolizumab and bevacizumab show meaningful responses for malignant peritoneal mesothelioma patients. MD Anderson Cancer Center. Retrieved from: https://www.mdanderson.org/newsroom/atezolizumab-and-bevacizumab-show-meaningful-responses-for-malignant-peritoneal-mesothelioma-patients.h00-159462423.html. Accessed: 02/22/2022.
- DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma (DREAM3R). Clinicaltrials.gov. Retrieved from: https://clinicaltrials.gov/ct2/show/NCT04334759. Accessed: 03/02/2022.
